Respirerx Pharmaceuticals Inc (RSPI)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [OTC US]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 09-2023 | 06-2023 | 03-2023 | 12-2022 | 09-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -1,507 | -1,111 | -430 | -2,103 | -1,813 |
| Depreciation Amortization | 136 | 11 | 7 | 391 | 382 |
| Other Working Capital | 1,158 | 980 | 422 | 1,369 | 1,353 |
| Other Operating Activity | -46 | -38 | -28 | 199 | -77 |
| Operating Cash Flow | $-259 | $-158 | $-29 | $-144 | $-155 |
| Cash Flows From Investing Activities | |||||
| Investing Cash Flow | $N/A | $N/A | $N/A | $N/A | $N/A |
| Cash Flows From Financing Activities | |||||
| Change In Short Term Borrowing | N/A | N/A | N/A | -95 | -76 |
| Debt Issued | 95 | 95 | N/A | 238 | 229 |
| Other Financing Activity | 170 | 70 | 29 | 0 | 0 |
| Financing Cash Flow | $265 | $165 | $29 | $143 | $154 |
| Beginning Cash Position | 0 | 0 | 0 | 1 | 1 |
| End Cash Position | 6 | 7 | 0 | 0 | 0 |
| Net Cash Flow | $6 | $7 | $0 | $-1 | $-1 |
| Free Cash Flow | |||||
| Operating Cash Flow | -259 | -158 | -29 | -144 | -155 |
| Free Cash Flow | -259 | -158 | -29 | -144 | -155 |